Rising Demand for Cyclin Dependent Kinase Market Key Players, Growth Analysis during 2021-2027
The global cyclin dependent kinase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cyclin-dependent kinases (CDKs) are protein kinases that are categorized by requiring a separate subunit, a cyclin. They provide domains essential for enzymatic activity and plays an important role in the control of cell division. Additionally, they modulate transcription in response to several extra- and intracellular cues. The major factor driving the growth of the market is the increasing prevalence of cancer across the globe.
To Request a Sample of our Report on Cyclin Dependent
Kinase Market:
https://www.omrglobal.com/request-sample/cyclin-dependent-kinase-market
According to the National Cancer
Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be
diagnosed in the US with a mortality rate of 606,520 people in 2020.
Additionally, the most common cancers include breast cancer, lung and bronchus
cancer, and leukemia, among others. In men, prostate, lung, and colorectal
cancers will account for an estimated 43% of all cancers diagnosed while for
women, the three most common cancers include breast, lung, and colorectal which
will account for an estimated 50% of all new cancer diagnoses in women in 2020.
Hence, the rising prevalence of cancer is supporting the demand for cyclin
dependent kinase to block uncontrolled cellular proliferation, which in turn,
is driving the growth of the market.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Route of Administration
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Pfizer Inc., Eli Lilly and
Company, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Cyclin Dependent Kinase Market is Available @ https://www.omrglobal.com/industry-reports/cyclin-dependent-kinase-market
Global Cyclin Dependent Kinase Market Report by Segment
By Type
·
Specific inhibitors
·
Non-Specific or Broad Range Inhibitors
·
Multiple target inhibitors
·
By Route of administration
·
Nasal
·
Oral
·
Intravenous
·
Intramuscular
By Application
·
Breast cancer
·
Lymphoma
·
Multiple Myeloma
·
Ovarian cancer
·
Others
Global Cyclin Dependent Kinase Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment